REtroperitoneal SArcoma Registry (RESAR): prospective collection of primary retroperitoneal sarcoma patient’s data, radiological and pathological material for the TransAtlantic Retroperitoneal Sarcoma Working Group.
Documents for activation of RESAR at new centers are available here.
Activation track of the study (updated December 20th 2020)
City | Institution | State | Activation Status | |
1 | Amsterdam | Netherlands Cancer Institute | The Netherlands | Recruiting |
2 | Atlanta | Winship Cancer Institute, Emory University | Georgia, USA | Recruiting |
3 | Barcelona | Hospital Sant Pau | Spain | Recruiting |
4 | Baton Rouge | Mary Bird Perkins Cancer Center | Louisiana, USA | Recruiting |
5 | Beijing | Peking University International Hospital | China | Recruiting |
6 | Birmingham | Queen Elizabeth Hospital Birmingham | UK | Recruiting |
7 | Bordeaux | Institut Bergonié | France | Recruiting |
8 | Boston | Brigham and Women’s Hospital/Dana-Farber Cancer Institute | Massachusetts, USA | Recruiting |
9 | Brisbane | Princess Alexandra Hospital | Australia | Recruiting |
10 | Buffalo | Roswell Park Comprehensive Cancer Center | New York, USA | Recruiting |
11 | Candiolo | Candiolo Cancer Institute | Italy | Recruiting |
12 | Columbus | The Ohio State University | Ohio, USA | Recruiting |
13 | Jacksonville | Mayo Clinic | Florida, USA | Recruiting |
14 | Leiden | Leiden University Medical Center | The Netherlands | Recruiting |
15 | Ljubljana | Institute of Oncology Ljubljana | Slovenia | Recruiting |
16 | London | Royal Marsden Hospital | UK | Recruiting |
17 | Los Angeles | University of Southern California (USC) | California, USA | Recruiting |
18 | Melbourne | Peter MacCallum Cancer Center | Victoria, Australia | Recruiting |
19 | Milano | Fondazione IRCCS Istituto Nazionale dei Tumori | Italy | Recruiting |
20 | Milano | European Institute of Oncology | Italy | Recruiting |
21 | Montreal | Maisonneuve-Rosemont Hospital / University of Montreal | Quebec, Canada | Recruiting |
22 | Munich | Ludwig Maximilian University | Germany | Recruiting |
23 | Murcia | Hospital Clinico Universitario “Virgen de la Arrixaca” | Spain | Recruiting |
24 | Ottawa | The Ottawa Hospital | Ontario, Canada | Recruiting |
25 | Padova | Veneto Institute of Oncology | Italy | Recruiting |
26 | Paris | Institut Curie | France | Recruiting |
27 | Roma | Campus Biomedico | Italy | Recruiting |
28 | Rozzano | Humanitas Cancer Center | Italy | Recruiting |
29 | San Diego | UC San Diego | USA | Recruiting |
30 | Seattle | University of Washington | Washington, USA | Recruiting |
31 | Seoul | Samsung Medical Center | South Corea | Recruiting |
32 | Tampa | Moffitt Cancer Center | Florida, USA | Recruiting |
33 | Tel-Aviv | Tel-Aviv Sourasky Medical Center | Israel | Recruiting |
34 | Tokyo | National Cancer Center Hospital | Japan | Recruiting |
35 | Toronto | Mount Sinai / Princess Margaret | Canada | Recruiting |
36 | Verona | Ospedale Borgo Roma | Italy | Recruiting |
37 | Warsaw | Maria Sklodowska-Curie Memorial Cancer Center and Institute ofOncology, Warsaw, | Poland | Recruiting |
1 | Dublin | Tallaght Univesity Hospital | Ireland | Approved, ready to recruit |
2 | Miami | Sylvester Comprehensive Cancer Center | Florida, USA | Approved, ready to recruit |
3 | Porto | Portuguese Institute for Oncology Porto IPO | Portugal | Approved, ready to recruit |
4 | Saitama | Saitama Medical Center, Jichi Medical University | Japan | Approved, ready to recruit |
5 | Sydney | Royal Prince Alfred Hospital | Australia | Approved, ready to recruit |
6 | Vellore | Christian Medical College | India | Approved, ready to recruit |
1 | Durham | Duke University | North Carolina, USA | Submitted to IRB, pending for decision |
2 | Karachi | Patel Hospital | Pakistan | Submitted to IRB, pending for decision |
3 | Montreal | McGill University | Canada | Submitted to IRB, pending for decision |
4 | Turin | Città della Salute e della Scienza | Italy | Submitted to IRB, pending for decision |
1 | Ann Arbor | University of Michigan | Michigan, USA | Planning to submit to IRB |
2 | Athens | University of Athens | Greece | Planning to submit to IRB |
3 | Baltimore | Johns Hopkins University | Maryland, USA | Planning to submit to IRB |
4 | Boston | Massachusetts General Hospital | Massachusetts, USA | Planning to submit to IRB |
5 | Catania | Ospedale Garibaldi | Italy | Planning to submit to IRB |
6 | Gent | Ghent University Hospital | Belgium | Planning to submit to IRB |
7 | Hong Kong | The Chinese University of Hong Kong / Prince of Wales Hospital | Hong Kong | Planning to submit to IRB |
8 | Leuven | UZ Leuven | The Netherlands | Planning to submit to IRB |
9 | Madrid | Hospital Gregorio Maranon | Spain | Planning to submit to IRB |
10 | Mexico City | Instituto National de Cancerologia | Mexico | Planning to submit to IRB |
11 | Milwaukee | Aurora St. Luke’s Medical Center | Wisconsin, USA | Planning to submit to IRB |
12 | Moskow | N.N. Blokhin Medical Research Center of Oncology | Russia | Planning to submit to IRB |
13 | Mumbai | Tata Memorial Hospital | India | Planning to submit to IRB |
14 | New Delhi | All India Institute of Medical Science AIIMS | India | Planning to submit to IRB |
15 | New Haven | Yale New Haven Hospital | Connecticut, USA | Planning to submit to IRB |
16 | Philadelphia | Fox Chase Cancer Center | Pennsylvania, USA | Planning to submit to IRB |
17 | Sacramento | UC Davis | California, USA | Planning to submit to IRB |